• Ipsos
  • Insights Hub
  • Conquering Complexity: The ongoing revolution in oncology biomarker testing

Conquering Complexity: The ongoing revolution in oncology biomarker testing

The clinical management of cancer patients has undergone a remarkable evolution in the last 15 years, with the concept of personalised medicine now well-entrenched in the treatment paradigm.

Conquering complexity | IpsosWe are also in the midst of much more radical revolution, however. The molecular diagnostics landscape – and the very way we think about fighting cancer – is set to change dramatically in the coming decades.

In this update of our 2017 edition of this paper, we combine new data from Ipsos’ Global Molecular Diagnostics Monitors with our current therapy expertise and market insight to outline key developments in the oncology diagnostics landscape, and the resulting impact on cancer treatment.

We also offer a forward-looking perspective on how we believe this landscape will shift, and how today’s touchpoints may look very different in years to come.

Download the full paper here.

 

In our accompanying podcast, the author, Pieter De Richter, talks us through the paper, offering his expert perspective on the future of oncology diagnostics.

Download

The author(s)

  • Pieter De Richter
    Pieter De Richter
    Regional Service Line Leader, Healthcare in APAC, Malaysia

More insights about Health

Related news

  • KEYS: Our World in Motion
    E mobility Webinar

    [Webinar] KEYS: Our World in Motion

    At our next KEYS webinar, we’ll be launching the inaugural Ipsos Mobility Report.
  • [Webinar] Real evidence from real experiences: Patient Centric Evidence
    Healthcare Webinar

    [Webinar] Real evidence from real experiences: Patient Centric Evidence

    Regulators, payers and clinicians are asking for more than traditional real world evidence (RWE). They want to understand how treatments affect people’s daily lives - not just what is written in the case report form. But how can you build patient-centric evidence that stands up to scientific, regulatory and commercial scrutiny?
  • Battle For Attention - KEYS Webinar from Ipsos
    Communications Events replay

    [Webinar] KEYS: Battle For Attention

    In today’s hyper-fragmented landscape, communicating using short-form content and social media platforms is an essential part of our toolkit. But are they better suited to short-term engagement rather than long-term brand building? And what does genuinely innovative and creative advertising look like these days?